The risk of secondary neoplasias following treatment of malignant germ cell tumours of the testis;Das Risiko sekundarer Neoplasien nach Behandlung maligner Keimzelltumoren des Hodens

Medizinische Klinik

Volumn 91, Issue 11, 1996, Pages 703-710

  Bokemeyer, Carsten ^a,b   Kuczyk, Markus A ^b   Könne, Claus Henning ^a   Haupt, Annette ^a   Schmoll, Hans Joachim ^a  

^a Abteilung Hämatologie Onkologie   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; VINBLASTINE;

CANCER CHEMOTHERAPY; CANCER RISK; GERM CELL TUMOR; HISTOLOGY; HUMAN; LEUKEMIA; REVIEW; SECOND CANCER; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; MALE; MULTIMODALITY CANCER THERAPY; NEOPLASM; RADIATION DOSE; RADIATION INJURY; RISK FACTOR; SEMINOMA; TESTIS TUMOR;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 0029972319     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Amichetti, M., S. Boi: Postirradiation sarcoma in a patient treated for testicular seminoma. Oncology 50 (1993), 264-266.
2. Auclerc, G., C. Jacquillat, F. Auclerc, M. Weil, J. Bernard: Post therapeutic acute leukemia. Cancer 44 (1979), 2017-2025.
3. Auxenfants, E., P. Morel, J. L. Lai, C. Sartiaux, L. Detourmignies, F. Bauten, P. Fenaux: Secondary acute lymphoblastic leukemia with t (4;11): report on two cases and review of the literature. Ann. Hematol, 65 (1992), 143-146.
4. Bajorin, D. F., R. J. Motzer, E. Rodriguez, B. Murphy, G. J. Bosl: Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. J. Nat. Cancer Inst. 85 (1993), 60-62.
5. Bokemeyer, C., M. Freund, H. J. Schmoll, H. Rieder, C. Fonatsch: Secondary lymphoblastic leukemia following treatment of a malignant germ cell tumour. Ann. Oncol. 3 (1992), 772.
6. Bokemeyer, C., H. J. Schmoll: Secondary neoplasms following treatment of malignant germ cell tumors. J. clin. Oncol. 11 (1993), 1703-1709.
7. Bokcmeyer, C., H. J. Schmoll, M. A. Kuczyk, J. Beyer, W. Siegert: Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer. J. Nat. Cancer Inst. 87 (1995), 58-60.
8. Bokemeyer, C., H. J. Schmoll, H. Poliwoda: Häufigkeit und Bedeutung des Auftretens von Sekundärleukämien nach Etoposid-haltiger Chemotherapie. Dtsch. med. Wschr. 119 (1994), 707-714.
9. Boshoff, C. H., R. H. J Begent, R. T. D. Oliver, G. J. Rustin, E. S. Newlands, R. Andrews, M. Skelton, L. Holden, J. Ong: Secondary tumours following etoposide containing therapy for germ cell cancer. Ann. Oncol. 6 (1995), 35-40.
10. Bosl, G. J., E. Dmitrovsky, V. Reuter, F. Samaniego, E. Rodriguez, N. L. Geller, N. S. Chaganti: Isochromosome of chromosome 12: clinically useful marker for male germ cell tumors. J. Nat. Cancer Inst. 81 (1989), 1874-1878.
11. Boyer, M., D, Raghavan: Toxicity of treatment of germ cell tumors. Semin. Oncol. 19 (1992), 128-142.
12. Coleman, M. P., C. M. J. Bell, P. Fraser: Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study. Brit. J. Cancer 56 (1987), 349-355.
13. Daugaard, G., M. Roerth: Treatment of poor-risk germ cell tumors with high-dose cisplatin and etoposide combined with bleomycin. Ann. Oncol. 3 (1992), 277-282.
14. DeVore, R., J. Whitlock, J. D. Hainsworth, D. H. Johnson: Therapy related acute nonlymphocytic leukemia with monocytic features and rearrangement of chromosome 11q, Ann. intern. Med. 110 (1989), 740-742.
15. Einhorn, L. H.: Karnofsky memorial lecture. Treatment of testicular cancer: a new and improved model. J. clin. Oncol. 8 (1990), 1777-1781.
16. Fossa, S. D., N. Aass, O. Kaalhus: Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients. Int. J. Radiat. Oncol. Biol Phys. 16 (1989), 383-388.
17. Fossa, S. D., F. Langmark, N. Aass, A. Andersen, R. Lothe, A. L. Borresen: Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Brit. J. Cancer 61 (1990), 639-643.
18. Gilks, B., C. Hegedus, H. Freeman, L. Fratkin, A. Churg: Malignant peritoneal mesothelioma after remote abdominal radiation. Cancer 61 (1988), 2019-2021.
19. Griffith, C. D., R. Chadderton, J. B. Bourke: Adenocarcinoma of the stomach following radical radiotherapy for testicular cancer. Europ. J. Surg. Oncol. 16 (1990), 68-69.
20. Hanks, G. E., T. Peters, J. Owen: Seminoma of the testis: long term beneficial and deleterious results of radiation. Int. J. Radiat. Oncol. Biol. Phys. 24 (1992), 913-919.
21. Hay, J. H., W. Duncan, G. R. Kerr: Subsequent malignancies in patients irradiated for testicular tumours. Brit. J. Radiol. 57 (1984), 597-602.
22. Hellbardt, A., R. O. Mirimanoff, M. Obradovic, B. Mermillod, J. P. Pannier: The risk of second cancer (sc) in patients treated for testicular seminoma. Int. J. Radiat. Oncol. Biol. Phys. 18 (1990), 1327-1331.
23. Hoekman, K., T. B. Huinink, M. A. Egbers-Bogaards, J. G. McVie, R. Somers: Acute leukemia following therapy for teratoma. Europ. J. Cancer Clin. Oncol. 20 (1984), 501-502.
24. Jacobsen, G. K., A. Mellemgaard, S. A. Engelholm, H. Moeller: Increased incidence of sarcoma in patients treated for testicular seminoma. Europ. J. Cancer 29 (1993), 664-668.
25. Kaldor, J. M., N. E. Day, P. Band, N. W. Choi, E. A. Clarke, M. P. Coleman, M. Hakama, M. Koch, F. Langmark, F. E. Neal: Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int. J. Cancer 39 (1987), 571-585.
26. Kaldor, J. M., F. Petterson, N. E. Day, E. A. Clarke, D. Pedersen, W. Mehnert, J. Bell, H. Host, P. Prior, S. Karjalainen: Leukemia following Hodgkin's disease. New Engl. J. Med. 322 (1990), 7-13.
27. Katsohi, D., M. Andreopoulos, Gofferjé, J. H. Karstens: Neuere Aspekte zur adjuvanten Therapie des Staduim-I-Seminoms. Med. Welt 45 (1994), 463-466.
28. Kleinerman, R. A., J. V. Lieberman, P. P. Li: Second cancer following cancer of the male genital system in Connecticut, 1935-1982. Nat. Cancer Inst. Monogr 68 (1985), 139-147.
29. LeBeau, M. M., K. S Albain, R. A. Larson, J. W. Vardimari, E. M. Davis, R. R. Blough, H. M. Golomb, J. D. Rowley: Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J. clin. Oncol. 4 (1986), 325-345.
30. Lynch, D. F., H. W. Herr: Radiation-induced sarcoma following radiotherapy for testicular tumor. J. Urol. 126 (1981), 845.
31. Moeller, H., A. Mellemgaard, G. K. Jacobsen, D. Pedersen, H. H. Storm: incidence of second primary cancer following testicular cancer. Europ. J. Cancer 29 (1993), 672-676.
32. Nichols, C. R., E. S. Breeden, P. J. Loehrer, S. D. Williams, L. H. Einhorn: Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols. J. Nat. Cancer Inst. 85 (1993), 36-40.
33. Nichols, C. R., B. J. Roth, N. Heerema, J. Griep, G. Tricot Hematologic neoplasia associated with primary mediastinal germ cell tumours. New Engl. J. Med 322 (1990), 1425-1429.
34. O'Brien, W. M., S. L. Abbondanzo, B. K. Chun, H. J. Manz, W C. Maxted: Neurogenic fibrosarcoma following radiation therapy for seminoma. Urology 33 (1989), 420-423.
35. Pedersen-Bjergaard, J., G. Daugaard, S. W. Hansen, P. Philip. S. O. Larsen, M. Rorth: Increased risk of myelodysplasia and leukemia after etoposide, cisplatin and bleomycin for germ cell tumors. Lancet 338 (1991), 359-363.
36. Pedersen-Bjergaard, J. P., P. Philip: Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II. Blood 78 (1991), 1147-1148.
37. Pui, C. H., C. Ribeiro, M. L. Hancock, G. K. Rivera, W. E. Evans, S. C. Raimond, D. R. Head, F. G. Behm, M. H. Mahmoud, J. T. Sandlund: Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. New Engl. J. Med. 325 (1991), 1682-1687.
38. Ratain, M. J., J. P. Rowley: Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: From the bedside to the target genes. Ann. Oncol. 3 (1992), 107-111.
39. Raz, H. R., R. Maurer, A. von Hochstetter, J. Hegglin: Angiosarkom nach Teratokarzinom: "Mutation", sukzessives Malignom oder Bestrahlung. Helv. chir. Acta 56 (1989), 355-357.
40. Redman, J. R., D. Vugrin, Z. A. Arlin, T. S. Gee, S. J. Kempin, J. H. Godbold, D. Schottenfeld, D. D. Clarksen: Leukemia following treatment of germ cell tumours in men. J. clin. Oncol. 2 (1984), 1080-1087.
41. Rokkas, T., T. J. Palmer, G. E. Sladen: Tumours of the pancreas as a sequel to abdominal irradiation. Postgrad. med. J. 65 (1993), 493-496.
42. Schmidt, A., D. Kob, H. Kosmehl: Zur Kenntnis strahlenbedingter Sarkome. Mitteilung über 2 Beobachtungen. Zbl. Allg. Path. 134 (1988), 41-45.
43. Smith, M. A., L. Rubinstein, L. Cazenave, R. S. Ungerleider, H. M. Maurer, R. Heyn, F. M. Khan, E. Gehan: Report of the cancer therapy evaluation program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins. J. Nat. Cancer Inn. 85 (1993), 554-558.
44. Steinfeld, A. D., R. E. Shore: Second malignancies following radiotherapy for testicular seminoma. Clin. Oncol. roy. Coll. Radiol. 2 (1990), 273-276.
45. Steward, A. L., P. M. Wilkinson: Rapid onset of acute myeloid leukemia following radiotherapy and chemotherapy for metastatic seminoma of the testis. J. Cancer Res. Clin. Oncol. 100 (1981), 108-111
46. Stock, R.J., Y. S. Fu, J. R. Carter. Malignant peritoneal mesothelioma following radiotherapy for seminoma of the testis. Cancer 44 (1979), 914-919.
47. Urba, W. J., D. L. Longo: Hodgkin's disease. New Engl. J. Med. 326 (1992), 678-687.
48. Van Imhoff, G. W., D. T. Sleijfer, M. H. Breuning, G. J. Anders, N. U. Mulder, M. R. Halie: Acute nonlymphocytic leukemia 5 years after treatment with cisplatin, vinblastine and bleomycin for disseminated testicular cancer. Cancer 57 (1986), 984-987.
49. Van Leeuwen, F. E., A. M. Stiggelbout, A. W. van den Belt-Dusebaut, R. Nayon, M. R. Eliel, E. H. van Kerkhoff, J. F. Delarmare, R. Somers: Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. J. clin. Oncol. 11 (1993), 415-424.
50. Williams, S. D., R. Birch, L. H. Einhorn, L. Irwin, P. A. Greco, P. J. Loehrer: Treatment of disseminated germ cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. New Engl. J. Med 316 (1987), 1435-1440.
51. Yoshitake, T., T. Takahama, T. Suzuki, T. Itoyama, T. Oka: Osteosarcoma developing after radiation and chemotherapy for primary mediastinal seminoma. Nippon Kyobu Geka Gakkai Zasshi 39 (1991), 424-429.